Article: Understand how Schering-Ploughs ethical sales are set to grow at a 2004-2010 CAGR of 7.4%, driven by Remicade, Zetia/Vytorin and the Intron franchise.

Article: Research and Markets: Understand How Schering-Plough's ...
Business Wire;  February 15, 2006 ;     700+ words ... ... order your copy: --Benchmark Schering-Plough's performance against ... pharmaceutical sector --Understand how Schering-Plough's ethical sales are set to grow at a 2004 ... competitive outlook 2004 --Schering-Plough's forecast revenue ...

Article: New Report Forecasts that Pharmaceutical Industry Ethical ...
M2 Presswire;  February 6, 2008 ;     700+ words ... ... Pharmaceutical Industry Ethical Sales Will Increase at a Modest ... pharmaceutical industry ethical sales will increase at a modest ... AstraZeneca PLC Bayer Schering Pharma AG Boehringer ... Inc Sanofi-Aventis Schering-Plough Corporation ...

Article: New Report Forecasts That Pharmaceutical Industry Ethical ...
Business Wire;  February 7, 2008 ;     700+ words ... ... forecasts that pharmaceutical industry ethical sales will increase at a modest 3.2% CAGR ... Astellas Pharma AstraZeneca PLC Bayer Schering Pharma AG Boehringer Ingelheim GmbH Bristol ... Management GmbH Pfizer Inc Sanofi-Aventis Schering-Plough Corporation Schwarz Pharma AG ...

Article: Research and Markets: Genentech's Ethical Sales ...
M2 Presswire;  June 10, 2005 ;     558 words ... ... Research and Markets: Research and Markets: Genentech's Ethical Sales Forecast to Grow from $3,749m in 2004 to $9,192m in ... It will give you an understanding as to why Genentech's ethical sales are forecast to grow from $3,749m in 2004 to $9,192m ...

Article: UK: Ethical sales to withstand recession - Co-op.
just-food.com;  November 28, 2008 ;     553 words ... ... according to figures in The Co-operative Bank's ninth annual report ion green spending in the country. The retailer said ethical sales had grown despite the "first tremors" of the downturn being felt towards the end of 2007. Green legislation and choice ...

Article: Research and Markets: Learn How Roche Is Forecast To Achieve The ...
Business Wire;  November 16, 2006 ;     643 words ... ... performance against key rivals in the ethical pharmaceutical sector * Learn how Roche is forecast to achieve the strongest ethical sales growth rate among the Big pharma peer set over 2005-11 * Understand how Roche is located in the high growth therapy areas ...

Article: Focus on the Schering-Plough Corporation Company Profile.
Business Wire;  November 29, 2007 ;     700+ words ... ... pharmaceutical sectorAnalyze how Schering-Plough's acquisition of ... diversification for the companyAssess Schering-Plough's continued forecast ... 2 Historical and forecast ethical sales performance 4 Therapeutic ... 35 M&A history 36 Schering Corp merger with Plough Corp ...